Company Filing History:
Years Active: 1994-2002
Title: Christophorus Joannes Meijer: Innovator in HPV Detection
Introduction
Christophorus Joannes Meijer is a notable inventor based in the Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the detection of human papillomavirus (HPV). His innovative approach aims to enhance the accuracy and efficiency of HPV detection methods, which are crucial in the prevention of cervical cancer.
Latest Patents
Meijer holds a patent for a groundbreaking invention titled "New Detection Method For Cervical HPVs." This invention describes a consensus PCR-based method, known as HRE7-PCR, for the simultaneous detection of 14 high-risk HPV types. These types include HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68, which are classified as probably high-risk in relation to cervical cancer causation. The method utilizes sets of 6 overlapping forward primers and 9 overlapping backward primers to amplify a fragment of approximately 215 to 245 base pairs of the E7 open reading frame of these HPV types. Additionally, an EIA format can be employed for the detection of reaction products using a cocktail of type-specific oligoprobes. Furthermore, Meijer has developed a method for efficient typing of these 15 HPVs, compatible with the detection method.
Career Highlights
Christophorus Joannes Meijer is associated with Self-Screen B.V., where he continues to work on innovative solutions in HPV detection. His expertise and dedication to improving medical diagnostics have positioned him as a key figure in this field.
Collaborations
Meijer collaborates with Petrus Josephus Snijders, contributing to advancements in HPV detection methodologies.
Conclusion
Christophorus Joannes Meijer is a pioneering inventor whose work in HPV detection is vital for cervical cancer prevention. His innovative methods and dedication to research continue to impact the medical field positively.